Our results provide a potential mechanistic basis of the synergistic effects of FMT and anti-PD-1 therapy on treating colorectal cancer, which will expand our knowledge on the mechanism of immunotherapy and assist with the development of novel anticancer therapy through modulating microbiota. This evidence concerns the gene PDCD1 and colorectal cancer.